Company Active LTD

Company profile

Unifai Technology Limited

403 Forbidden

Unifai Technology Limited is a UK company with status active founded in 2019 based in London.

CRN
12301340
Founded
2019
Age
6

Overview

Legal name
UNIFAI TECHNOLOGY LIMITED
Region
London
Registered address
3RD FLOOR
86-90 PAUL STREET
LONDON
ENGLAND
EC2A 4NE
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

9 events
26 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

08 Apr
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUxNTAzNTMwMmFkaXF6a2N4

Published 08 Apr 2026 19:09

08 Apr
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUxNTAzNDk0NmFkaXF6a2N4

Published 08 Apr 2026 19:03

12 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

02 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzODExMzIzM2FkaXF6a2N4

Published 02 Oct 2024 09:15

17 Sep
2024

Accounts With Accounts Type Unaudited Abridged

Accounts Analysed

AA | Transaction MzQzNjIxODUyMmFkaXF6a2N4

Published 17 Sep 2024 14:22

06 Nov
2019

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2020
Funded years
2020, 2021, 2023
Age at first award
0 years

Projects

2023 Collaborative R&D

Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsis

1 Jan 2023 to 30 Sep 2024

Awarded
£48,721
Total cost £69,601

Neutropenic sepsis (NS) is a life-threatening complication of cancer chemotherapy. It occurs because chemotherapy temporarily suppresses the immune system, particularly neutrophil cells, and even mild illnesses can be fatal for patients during this time. As a result, if any chemotherapy patient has a fever or feels unwell they are advised to attend hospit...

2021 Collaborative R&D Lead participant

Carbon Sequestration of Soil - converging sensing with AI to monitor the quality and carbon carrying capacity of soil

1 Jan 2021 to 31 Mar 2021

Awarded
£82,190
Total cost £102,769

COVID-19 hit the agriculture sector hard. Farmers need new, diverse sources of revenue if we are to maintain a thriving UK rural economy. The Agriculture and Horticulture Development Board (AHDB) estimates dairy farmers alone lost £28m in April and May due to COVID-19\. At the same time, climate change is probably the largest single threat to our planet a...

2020 Feasibility Studies Lead participant

Supporting critical food supply chains

1 Jul 2020 to 31 Mar 2022

Awarded
£149,621
Total cost £149,621

Maintaining food supply chains during the COVID-19 crisis is critical. Workers in this sector are being asked to stay at work for the benefit of their local communities, and the entire country - from supermarket employees to delivery drivers and more. Keeping critical food supply chain workers safe, customers safe, and communities safe is essential. This ...

Product types

Collaborative R&D Feasibility Studies